Logo image
Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle
Journal article   Open access   Peer reviewed

Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle

Vitor A Lira, Quinlyn A Soltow, Jodi H D Long, Jenna L Betters, Jeff E Sellman and David S Criswell
American journal of physiology: endocrinology and metabolism, Vol.293(4), pp.E1062-1068
10/2007
DOI: 10.1152/ajpendo.00045.2007
PMID: 17666490
url
https://doi.org/10.1152/ajpendo.00045.2007View
Published (Version of record) Open Access

Abstract

Nitric oxide (NO) and 5'-AMP-activated protein kinase (AMPK) are involved in glucose transport and mitochondrial biogenesis in skeletal muscle. Here, we examined whether NO regulates the expression of the major glucose transporter in muscle (GLUT4) and whether it influences AMPK-induced upregulation of GLUT4. At low levels, the NO donor S-nitroso-N-penicillamine (SNAP, 1 and 10 microM) significantly increased GLUT4 mRNA ( approximately 3-fold; P < 0.05) in L6 myotubes, and cotreatment with the AMPK inhibitor compound C ablated this effect. The cGMP analog 8-bromo-cGMP (8-Br-cGMP, 2 mM) increased GLUT4 mRNA by approximately 50% (P < 0.05). GLUT4 protein expression was elevated 40% by 2 days treatment with 8-Br-cGMP, whereas 6 days treatment with 10 microM SNAP increased GLUT4 expression by 65%. Cotreatment of cultures with the guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one prevented the SNAP-induced increase in GLUT4 protein. SNAP (10 microM) also induced significant phosphorylation of alpha-AMPK and acetyl-CoA carboxylase and translocation of phosphorylated alpha-AMPK to the nucleus. Furthermore, L6 myotubes exposed to 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside (AICAR) for 16 h presented an approximately ninefold increase in GLUT4 mRNA, whereas cotreatment with the non-isoform-specific NOS inhibitor N(G)-nitro-l-arginine methyl ester, prevented approximately 70% of this effect. In vivo, GLUT4 mRNA was increased 1.8-fold in the rat plantaris muscle 12 h after AICAR injection, and this induction was reduced by approximately 50% in animals cotreated with the neuronal and inducible nitric oxide synthases selective inhibitor 1-(2-trifluoromethyl-phenyl)-imidazole. We conclude that, in skeletal muscle, NO increases GLUT4 expression via a cGMP- and AMPK-dependent mechanism. The data are consistent with a role for NO in the regulation of AMPK, possibly via control of cellular activity of AMPK kinases and/or AMPK phosphatases.
Cyclic GMP - pharmacology Muscle, Skeletal - enzymology Glucose Transporter Type 4 - genetics Glucose Transporter Type 4 - metabolism Signal Transduction Nitric Oxide - pharmacology Cells, Cultured Nitric Oxide Synthase - antagonists & inhibitors Rats Muscle, Skeletal - metabolism Enzyme Activation - drug effects Rats, Sprague-Dawley Aminoimidazole Carboxamide - pharmacology Gene Expression Regulation - drug effects Ribonucleotides - pharmacology Animals Aminoimidazole Carboxamide - analogs & derivatives Models, Biological Adenylate Kinase - metabolism Muscle, Skeletal - drug effects Female

Details

Metrics

113 readers on Mendeley
2 readers on CiteULike
Logo image